Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Tablets, Capsules, Powders, Granules, Others)
5.2.2. By End User (Large-size companies, Small & medium size companies, Startups and generic pharmaceutical companies)
5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.4. By Company (2022)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By End User
5.3.3. By Region
6. North America Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By End User
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By End User
6.3.2. Canada Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By End User
6.3.3. Mexico Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By End User
7. Europe Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By End User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By End User
7.3.2. France Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By End User
7.3.3. United Kingdom Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By End User
7.3.4. Italy Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By End User
7.3.5. Spain Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By End User
8. Asia-Pacific Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By End User
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By End User
8.3.2. Japan Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By End User
8.3.3. India Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By End User
8.3.4. South Korea Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By End User
8.3.5. Australia Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By End User
9. South America Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By End User
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By End User
9.3.2. Argentina Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By End User
9.3.3. Colombia Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By End User
10. Middle East and Africa Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By End User
10.3.2. Saudi Arabia Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By End User
10.3.3. South Africa Oral Solid dosage (OSD) Contract Manufacturing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition
12.2. Product Development
12.3. Recent Developments
13. Competitive Landscape
13.1. Business Overview
13.2. Company Snapshot
13.3. Products & Services
13.4. Financials (As Reported)
13.5. Recent Developments
13.5.1. AbbVie Inc.
13.5.1.1. Business Overview
13.5.1.2. Company Snapshot
13.5.1.3. Products & Services
13.5.1.4. Financials (As Reported)
13.5.1.5. Recent Developments
13.5.2. Acino International AG
13.5.2.1. Business Overview
13.5.2.2. Company Snapshot
13.5.2.3. Products & Services
13.5.2.4. Financials (As Reported)
13.5.2.5. Recent Developments
13.5.3. Aenova Holding GmbH
13.5.3.1. Business Overview
13.5.3.2. Company Snapshot
13.5.3.3. Products & Services
13.5.3.4. Financials (As Reported)
13.5.3.5. Recent Developments
13.5.4. Beximco Pharmaceuticals Ltd.
13.5.4.1. Business Overview
13.5.4.2. Company Snapshot
13.5.4.3. Products & Services
13.5.4.4. Financials (As Reported)
13.5.4.5. Recent Developments
13.5.5. Boehringer Ingelheim International GmbH
13.5.5.1. Business Overview
13.5.5.2. Company Snapshot
13.5.5.3. Products & Services
13.5.5.4. Financials (As Reported)
13.5.5.5. Recent Developments
13.5.6. Catalent Inc.
13.5.6.1. Business Overview
13.5.6.2. Company Snapshot
13.5.6.3. Products & Services
13.5.6.4. Financials (As Reported)
13.5.6.5. Recent Developments
13.5.7. Corden Pharma International GmbH,
13.5.7.1. Business Overview
13.5.7.2. Company Snapshot
13.5.7.3. Products & Services
13.5.7.4. Financials (As Reported)
13.5.7.5. Recent Developments
13.5.8. PerkinElmer Inc.
13.5.8.1. Business Overview
13.5.8.2. Company Snapshot
13.5.8.3. Products & Services
13.5.8.4. Financials (As Reported)
13.5.8.5. Recent Developments
13.5.9. Pyramid Laboratories Inc.
13.5.9.1. Business Overview
13.5.9.2. Company Snapshot
13.5.9.3. Products & Services
13.5.9.4. Financials (As Reported)
13.5.9.5. Recent Developments
13.5.10. Siegfried AG
13.5.10.1. Business Overview
13.5.10.2. Company Snapshot
13.5.10.3. Products & Services
13.5.10.4. Financials (As Reported)
13.5.10.5. Recent Developments
14. Strategic Recommendations